Breast Cancer Trials

Breast Cancer Trials is committed to exploring and finding better treatments for people affected by breast cancer through clinical trials research. We are a group of world-leading breast cancer researchers based in Australia and New Zealand, supported by a team of professional staff who manage our clinical trials and raise the money we need to do the work we do. Our research has improved the treatment of breast cancer, led to changes in the way breast cancer is managed, and saved the lives of millions of people affected by breast cancer since our inception in 1978. Our goal is for breast cancer patients to live better, to live longer, and to never die from breast cancer. The work we do and the decisions we make serve the common good of all people who are affected with breast cancer, as we strive every day to make the world a better place. Organisations don’t make things happen; people do. Are you one of these people? Find out more: https://lnkd.in/g3ZtRBP9

NEW PODCASTS OUT NOW! We have a number of new podcasts available to listen to, and more to come, including interviews with clinical trials participants, researchers, and our new Breast Cancer Trials Clinical Fellows. You can listen to the Breast Cancer Trials Podcast on Apple Podcasts, Spotify, Google Podcasts, or on our Research Blog here: https://lnkd.in/dvYfTZtd Tune into our discussions with our world-leading breast cancer experts, clinical trial participants, and women who have been diagnosed with breast cancer. And don't forget to rate and subscribe while you're there!

The research conducted by Breast Cancer Trials over the years has saved lives and improved patients' quality of life. From better, gentler treatments and new knowledge to help guide treatment decisions, Breast Cancer Trials has impacted the lives of many people. Find out more: https://lnkd.in/gjpaetti

Did you know that all information collected before, during and after a clinical trial remains confidential and will only be used for approved purposes? Visit our website for more information about how patient confidentiality is ensured during clinical trials.🔬🔬🔬 Find out more: https://lnkd.in/gaKkQrwk

Introducing the OLIO clinical trial! OLIO aims to find out if the addition of olaparib, or a combination of olaparib and durvalumab, given together with standard chemotherapy, can help to control cancer in pre-menopausal women with HR-positive, HER2-negative breast cancer. Young patients with HR-positive, HER2-negative breast cancer are often treated with hormone therapy and chemotherapy and have a 2-3x increased risk of breast cancer recurrence over their lifetime. It is believed that targeted treatments in addition to chemotherapy could improve patient outcomes for young, early breast cancer patients. Through a combination of these treatments, we hope that this will deliver an improved approach to the treatment of breast cancer in young women who have a high risk of relapse and will improve patient outcomes. To find out more about this important research visit: https://lnkd.in/gvrbHYT3

Are you eligible for the BRCA-P clinical trial? Women with a BRCA1 gene mutation have a 70% risk of developing breast cancer over their lifetime. That's why the BRCA-P clinical trial has the potential to be a game-changer in breast cancer prevention. We are investigating if an injection of the drug denosumab, twice yearly for five years, is a safe and effective way of preventing breast cancer for women with a BRCA1 gene mutation. If you have a confirmed BRCA1 gene mutation, are aged between 25-55, have not received a breast cancer diagnosis, and have not completed surgery to remove both breasts, you could be eligible for this trial. Learn more about this very important research here: https://lnkd.in/g8UgBwj

Missed our latest Q&A on the topic of Breast Cancer and Heart Health? Click the link below to watch the recording of this fantastic discussion. Thanks to our wonderful panel of speakers for their thoughtful insights and advice. We hope you enjoyed this session! Keep an eye out for our next Q&A in the near future! https://lnkd.in/djXDwMPP

Clinical trials conducted by Breast Cancer Trials are recognised for their practice-changing results. All new treatments and prevention strategies must be rigorously tested before they are made available in the community, with patient safety being the number one priority for our researchers. 🧪🧪🧪 Find out more https://lnkd.in/gaKkQrwk

Do you know your breast cancer risk? iPrevent is an online tool to help women understand their breast cancer risk and act on it. iPrevent asks women, or their clinician, to first enter family and personal history, lifestyle and reproductive risk factor information. Using that information, it then provides 10-year and residual life-time risk estimates. Try it here: https://lnkd.in/ggJ4f7s

Happy National Science Week! Without our amazing researchers who dedicate their working lives to furthering science and knowledge, there could be no advancements in breast cancer treatment Thank you for everything you do for those affected by breast cancer! ❤️